Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
16.55
+0.80 (5.08%)
Mar 7, 2025, 4:00 PM EST - Market closed
Bicara Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Bicara Therapeutics stock have an average target of 39.5, with a low estimate of 31 and a high estimate of 47. The average target predicts an increase of 138.67% from the current stock price of 16.55.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Bicara Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $31 | Buy | Reiterates | $31 | +87.31% | Feb 12, 2025 |
| Wedbush | Wedbush | Buy Initiates $31 | Buy | Initiates | $31 | +87.31% | Feb 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $42 → $45 | Strong Buy | Maintains | $42 → $45 | +171.90% | Jan 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +153.78% | Dec 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 8, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.65
from -89.61
EPS Next Year
-1.75
from -2.65
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.45 | -1.49 | -1.95 |
| Avg | -2.65 | -1.75 | -2.26 |
| Low | -3.77 | -2.45 | -2.70 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.